# Maestro

Manufacturer: [Moon Surgical](/companies/moon-surgical)  
Category: surgical

## Summary

Moon Surgical's Maestro is a laparoscopic surgical-assistant platform (it holds and positions instruments and the endoscope alongside the surgeon, not a full master-slave teleoperated replacement system) and the assistive-laparoscopy archetype of DEPLOY's surgical cluster, editorially distinct from the replacement-robotics of Intuitive, Medtronic, and CMR. Its ScoPilot software is shipped AI (NVIDIA Holoscan-powered) for intraoperative scope control. On regulatory status (a correction worth recording): the Maestro received FDA 510(k) clearance K240598 on June 5, 2024 (not December 2023), and ScoPilot was FDA-cleared in 2025 with a Predetermined Change Control Plan. As enterprise B2B surgical equipment, there is no consumer price.

## Top line

> Maestro is internal use only (not for retail), no capability claims are on file, the model has no verified field deployments in the registry, and no incidents are on record.

## Readiness

- **Availability** (internal-only): Internal use only (not for retail).
- **Price honesty** (no-price): No price points on file for Maestro.
- **Capability honesty** (no-claims): No reviewed capability claims on file for Maestro.
- **Real-world use** (commercial): Maturity: commercial. No verified deployments in the registry.
- **Safety record** (no-incidents): No incidents on record. No verified deployments either.

## What it claims to do

_No reviewed capability claims on file._

## Price

_No reviewed price points on file._

## Real-world use

_No verified deployments on file for Maestro._

## Safety record

_No incidents on record. No verified deployments either, so the absence is uninformative._

## Privacy

_No privacy practices disclosed or on file for Maestro._

## Specs

- **notes**: [{"label":"Verified","value":"Moon Surgical (private; Paris + San Carlos CA; CEO Anne Osdoit; board chair Fred Moll, Intuitive co-founder; backers Sofinnova + NVentures/NVIDIA) makes Maestro, a laparoscopic surgical-ASSISTANT/collaboration robot (holds/positions instruments alongside the surgeon, not a full teleop console). Commercial Maestro FDA 510(k)-cleared Jun 5 2024 (K240598); >1,100 patients treated across US + Europe (company-stated). ~$90M+ raised."},{"label":"AI-substance: genuine SHIPPED AI (notable)","value":"ScoPilot is a genuine SHIPPED, FDA-cleared AI feature (intraoperative scope control via NVIDIA Holoscan), with a PCCP - not merely demonstrated. This distinguishes Maestro from the teleop-only platforms in this cohort. Maestro itself is a collaborative/assist robot (an honest distinction from full master-slave teleop)."},{"label":"CORRECTION (pathway)","value":"Maestro went the 510(k) route (K240598), NOT de novo (the dispatch hypothesized de novo). De novo around that time was Virtual Incision/MIRA and MMI/Symani - different companies."},{"label":"Claimed but NOT verified","value":"CE mark status/date (unverified this pass); exact installed-system count; the 'industry's first AI on a commercial surgical robot' superlative (marketing); the >1,100-patients figure (company-sourced)."}]
- **products**: Maestro: a laparoscopic surgical-assistant platform (holds/positions instruments + endoscope alongside the surgeon). ScoPilot: shipped AI software (NVIDIA Holoscan-powered) for intraoperative scope control. Commercial Maestro FDA 510(k) K240598 cleared Jun 5 2024; ScoPilot FDA-cleared 2025 with a Predetermined Change Control Plan (PCCP).
- **formFactor**: surgical (laparoscopic surgical-assistant / collaboration robot: holds + positions instruments alongside the surgeon; not full master-slave teleop)

## What's under the hood

_No brain on file for Maestro._

## Frequently asked questions

### Is the Maestro actually available for purchase?

Not available to consumers. In internal use by Moon Surgical.

_Source: [Moon Surgical: 2nd FDA clearance covering the commercial Maestro system (Jun 2024)](https://www.prnewswire.com/news-releases/moon-surgical-second-fda-clearance-commercial-maestro)._

### What does the Maestro cost?

Not announced.

### Where is the Maestro being used?

No verified field deployments on record.

### Is the Maestro safe?

No incidents on record, but with no verified field deployments either, the absence is uninformative.

### How does the Maestro handle privacy?

No privacy practices disclosed or on file for Maestro.

### Who makes the Maestro?

Maestro is made by Moon Surgical, based in San Carlos, California, USA.

_Source: [Moon Surgical: 2nd FDA clearance covering the commercial Maestro system (Jun 2024)](https://www.prnewswire.com/news-releases/moon-surgical-second-fda-clearance-commercial-maestro)._

## Manufacturer

- [Moon Surgical (https://www.prnewswire.com/news-releases/moon-surgical-second-fda-clearance-commercial-maestro)](https://www.prnewswire.com/news-releases/moon-surgical-second-fda-clearance-commercial-maestro)

## Compared to

- [Hugo RAS](/consumer/models/medtronic-hugo)

## Sources

1. [Moon Surgical: 2nd FDA clearance covering the commercial Maestro system (Jun 2024)](https://www.prnewswire.com/news-releases/moon-surgical-second-fda-clearance-commercial-maestro)
2. [FDA 510(k) K240598: Maestro System (cleared Jun 5 2024)](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K240598)
3. [Moon Surgical ScoPilot AI FDA clearance (with PCCP; NVIDIA Holoscan)](https://www.biospace.com/moon-surgical-scopilot-fda-nvidia-holoscan)
4. [Moon Surgical raises $55.4M; Fred Moll board chair; NVentures-backed](https://www.massdevice.com/moon-surgical-funding-fred-moll/)

_Canonical: https://deploy.report/models/moon-maestro_